New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity -- and potentially pandemic preparedness.
The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...
Researchers have developed a breath-based in vitro assay that accurately detects lower respiratory tract infections (LRTIs) ...
Rahul Gandhi and Mallikarjun Kharge honored the late CPI(M) leader Sitaram Yechury, acknowledging his unwavering commitment ...
Objective To explore associations between maternal body mass index (BMI) in early pregnancy and childhood infections. Design ...
Over half of healthy U.S. infants contract RSV in their first year, according to a Vanderbilt University Medical Center study ...
Background Healthcare-associated infections due to multidrug-resistant organisms (MDROs) remain a high priority patient ...
2009; Thiry et al., 2009). Signs of erosion and ulceration of the mucosal surfaces are generally associated with FCV and FeHV-1 infection (Palombieri et al., 2022), and severe systemic signs involving ...
Positive Phase III Results for Genentech’s Gazyva Show Superiority to Standard Therapy Alone in People With Lupus Nephritis ...
Current strategies to prevent severe RSV disease in infants include maternal vaccination with the RSV prefusion F vaccine ...
More than half of healthy term infants born in the United States are infected with respiratory syncytial virus (RSV) during ...
Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback